Viewing Study NCT00523120



Ignite Creation Date: 2024-05-05 @ 6:41 PM
Last Modification Date: 2024-10-26 @ 9:35 AM
Study NCT ID: NCT00523120
Status: TERMINATED
Last Update Posted: 2016-04-20
First Post: 2007-08-28

Brief Title: Topical Voltaren in Otitis Externa
Sponsor: Sieff Medical Center
Organization: Sieff Medical Center

Study Overview

Official Title: Topical Voltaren as an Alternative Treatment for Otitis Externa
Status: TERMINATED
Status Verified Date: 2016-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Voltaren being a Non-steroidal anti-inflammatory drug NSAID drug may be used as a single drug therapy in otitis externa being both therapeutic and analgesic thus reducing consumption of oral analgesia
Detailed Description: anticipated advantages are reduction of inflammation and edema no fungal overpopulation- when steroids are employed contains boric acid as an ingredient high safety profile can be switched to antibiotic therapy later can be used in conjunction wit steroids

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None